※ 출처: ClinicalTrials.gov
총 385건

해외임상승인현황 정보 :: 순번, 임상시험 제목, 적응증, 연구설계, 의뢰자/실시기관, 임상단계, 게시일자
순번 임상시험 제목 적응증 연구설계 의뢰자/실시기관 임상단계 게시일자
1 A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy Carcinoma, Non-small Cell Lung Cancer Biological: nivolumab|Biological: ipilimumab|Drug: cabozantinib|Biological: docetaxel|Biological: ramucirumab|Drug: lucitanib Bristol-Myers Squibb|Clovis Oncology, Inc.|Exelixis|Eli Lilly and Company Phase 1|Phase 2 2021-04-15
2 Efficacy, Safety, and Tolerability of V937 Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011) Advanced/Metastatic Melanoma Biological: V937 IV|Biological: V937 IT|Drug: Pembrolizumab Merck Sharp & Dohme Corp. Phase 2 2020-06-05
3 To Compare the PK and Safety of Omalizumab(CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects Healthy Biological: CT-P39|Biological: EU-approved Xolair|Biological: US-licensed Xolair Celltrion Phase 1 2020-05-28
4 Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) Compensated Cirrhosis|Nonalcoholic Steatohepatitis Biological: aldafermin|Other: Placebo NGM Biopharmaceuticals, Inc Phase 2 2020-03-23
5 Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus (SLE) Drug: AMG 570|Drug: Placebo for AMG 570 Amgen Phase 2 2020-02-19
6 Study of NGM395 in Adult Participants Obesity|NAFLD Biological: NGM395|Other: Placebo NGM Biopharmaceuticals, Inc Phase 1 2020-02-13
7 Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991) Metastatic Hormone-Sensitive Prostate Cancer Biological: Pembrolizumab|Drug: Enzalutamide|Procedure: Androgen Deprivation Therapy (ADT)|Other: Placebo Merck Sharp & Dohme Corp. Phase 3 2020-02-12
8 A Study of Nivolumab Plus NKTR-214 vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That Has Invaded the Muscle Wall of the Bladder and Who Cannot Get Cisplatin, a Type of Medicine Given to Treat Bladder Cancer. Bladder Cancer|Bladder Tumor|Muscle-Invasive Bladder Cancer Biological: Nivolumab|Biological: NKTR-214|Procedure: Radical cystectomy (RC) Bristol-Myers Squibb|Nektar Therapeutics Phase 3 2020-01-23
9 Safety and Efficacy of Capmatinib (INC280) Plus Pembrolizumab vs Pembrolizumab Alone in NSCLC With PD-L1≥ 50% Non-Small Cell Lung Cancer (NSCLC) Drug: Capmatinib|Biological: Pembrolizumab Novartis Pharmaceuticals|Novartis Phase 2 2020-01-22
10 Efficacy and Safety of XT-150 in Osteoarthritis of the Knee Osteoarthritis, Knee Biological: XT-150 Xalud Therapeutics, Inc. Phase 2 2020-01-07